Dr. Ravi N. Srinivasa, MD

Dr. Srinivasa practices at Santa Clarita Radiation Oncology - Radiation Oncology - HOPD in Santa Clarita, California.

Dr. Srinivasa's NPI, 1134333768, was assigned on May 10, 2007. Dr. Srinivasa graduated from Texas Tech University Health Sciences Center School of Medicine in 2006. Dr. Srinivasa holds California license C151583.

Dr. Srinivasa's primary practice is Santa Clarita Radiation Oncology - Radiation Oncology - HOPD, at 27235 Tourney Rd, Santa Clarita, CA 91355.

Dr. Srinivasa's primary practice is Santa Clarita Radiation Oncology - Radiation Oncology - HOPD in Santa Clarita, California. Dr. Srinivasa is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Entertainment Industry Medical Group. Dmand AI also links Dr. Srinivasa to 2 more hospitals, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Srinivasa practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Srinivasa's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Srinivasa is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Srinivasa's licenses on file in 4 states: California, Texas, Michigan and Pennsylvania.

CMS data shows 790 Medicare services from Dr. Srinivasa across 12 procedure codes in 2024, for 303 Medicare patients. Medicare paid $54,534 for them.

CMS counts 303 Medicare patients who saw Dr. Srinivasa in 2024. The largest group is 65 to 74, with 129 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Srinivasa's median patient age at 65, with 57% women.

In 2024, Dr. Srinivasa wrote 33 Medicare Part D claims for 15 patients. 82% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $66 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Srinivasa for performance year 2024, reported as part of a group. Dr. Srinivasa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Srinivasa as offering telehealth.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 57 papers to Dr. Srinivasa, published from 2016 to 2020. 2018 was the busiest year, with 19. The most frequent topics are Social Media and Physicians. Dr. Srinivasa has published most often in J Vasc Surg Venous Lymphat Disord. Dr. Srinivasa's most frequent co-authors are Anthony Nelson Hage, MD, Joseph John Gemmete, MD and Rajiv N. Srinivasa, MD.

Dmand AI links Dr. Srinivasa to 1 clinical trial. Conditions studied include Pulmonary Embolism and Embolism.

CMS Open Payments shows 252 general payments to Dr. Srinivasa from 22 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Boston Scientific Corporation paid the most, $87,787.

Dr. Srinivasa graduated from Texas Tech University Health Sciences Center School of Medicine in 2006. Dr. Srinivasa is a member of SIR.

Dr. Srinivasa is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.